It cost over $3 billion and took almost 13 years to sequence the human genome for the first time, a task that was only completed a little over ten years ago. Instead of our current one-size-fits all treatment for most diseases, many envision a future in which we will be able to tailor medical treatment based on ones underlying genetic information, a medical model known as personalized, or precision, medicine. To better understand what it will take to reach these aims, which will require further advances in many disciplines and have implications stretching far beyond the field of medicine, University President Lee Bollinger recently announced the creation of a task force on personalized medicine. When there are major advances in our knowledge that can be translated in very important effects for the world, we want to make sure as the university we are doing everything we can to facilitate that, Bollinger said at last weeks University Senate plenary. The task force, co-chaired by Provost John Coatsworth and Dean of the Faculties of Health Sciences and Medicine Lee Goldman, brings together almost 40 faculty members across the entire university. Unlike other institutions, including various cancer centers, that are also working in … Continue reading →

March 10, 2014 Rebekah Eliason for redOrbit.com Your Universe Online A study from Northwestern Medicine has led to a new theory regarding the development and cause of endometriosis. The chronically painful disease, which affects 1 in 10 women, has been linked to two previously unstudied genes. This innovative research regarding endometriosis suggests that an integral part of the disease and its progression is epigenetic modification, which is a process that will either enhance or disrupt the reading of DNA. Matthew Dyson, research assistant professor of obstetrics and gynecology at Northwestern University Feinberg School of Medicine, along with Serdar Bulun, MD, chair of obstetrics and gynecology at Feinberg and Northwestern Memorial Hospital, were able to recognize a novel role for a family of key gene regulators found in the uterus. Until now, the scientific community was looking for a genetic mutation to explain endometriosis, said Bulun, a member of the Center for Genetic Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. This is the first conclusive demonstration that the disease develops as a result of alterations in the epigenetic landscape and not from classical genetic mutations. Heather C. Guidone, Surgical Program Director at The Center for Endometriosis … Continue reading →

Freeport, The Bahamas (PRWEB) March 10, 2014 Matt Feshbach, CEO of Okyanos Heart Institute whose mission it is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy has announced the appointment of Okyanos senior vice president of marketing, Erika Rosenthal, to the International Stem Cell Society (STEMSO) Advisory Board. She will advise the trade organization in a communications capacity to benefit the membership and the mission. STEMSO is a member-based, international, non-profit 501(c) 6 trade association which promotes the interests of organizational members of the global, adult stem cell healthcare community. STEMSO provides information, education, resources, advocacy and public awareness for the advancement of adult stem cell research and therapy. The organization recently hosted a global regenerative medicine conference in Freeport, The Bahamas, entitled, Bridging the Gap: Research to Point of Care which brought together experts in adult stem cell therapy and regulations to discuss commercialization of therapies for chronic disease in a safe, ethical, and compliant manner. STEMSO is an important organization to the field of stem cell therapy and research, said Feshbach. Communications and healthcare are both fields in which Erika excels, and so … Continue reading →

Miami (PRWEB) March 10, 2014 Regenestem, Inc., a division of Global Stem Cells Group, has announced plans to build the first Regenestem brand clinic in the Philippines. The planned, 22,000 square foot, state-of-the-art medical facility in Manila will focus on providing the latest stem cell-based anti-aging and cosmetic therapies available, eliminating the need for invasive surgery. Regenestem is collaborating with distinguished Philippine Cosmetic Surgeon Eric Yalung, M.D. of the Cosmetic Surgery Institute-Manila, Inc. to create the stem cell therapy center, offering the most advanced protocols in cosmetic cellular medicine to patients from around the world. The new Regenestem clinic will be headed by Yalung, a prominent and popular cosmetic surgeon in Manila who has built a reputation for incorporating the latest, most modern and least-invasive techniques in aesthetic medicine into his practice. Yalung will be joined by a team of talented stem cell specialists to provide patient treatment and follow-up care under the Regenestem brand. Regenestem currently offers stem cell treatments for arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes and multiple sclerosis among other conditions at various facilities worldwide As part of its commitment to maintaining the highest standards in service and technology, Regenestem provides an international staff and … Continue reading →

Brown Symposium XXXVI - Mauro Ferrari: "Nanomedicine and New Societal Horizons" Southwestern University's Brown Symposium in 2014 examined the scientific foundations and the human dimensions of healing, their interaction, and how both in... By: Southwestern University … Continue reading →

Stem Cell Treatment with Dr. Balshi Dr. Balshi has had great results helping MS patients with the Stem Cell Treatment. He explains the procedure of activating the stem cells extracted from the ... By: Choose JOY MS Relief … Continue reading →